您的位置: 首页 > 2023年5月 第54卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

术前控制营养状态评分在老年胃癌患者术后短期并发症中的应用价值

Application value of controlling nutritional status score in short-term postoperative complications of elderly patients with gastric cancer

来源期刊: 广州医药 | 28-35 发布时间:2023-07-12 收稿时间:2025/11/13 18:34:14 阅读量:37
作者:
关键词:
胃癌老年控制营养状态术后并发症
gastric cancerelderlycontrolling nutritional statuspostoperative complications
DOI:
10.3969/j.issn.1000-8535.2023.05.005
收稿时间:
2022-08-04 
修订日期:
 
接收日期:
 
引用总数:
2  
目的 探讨术前控制营养状态评分在老年胃癌患者术后短期并发症中的应用价值。方法 回顾分析统计2015年1月—2020年12月在江苏大学附属医院接受治疗的确诊胃癌患者,根据纳入标准和排除标准,选择入组患者,收集纳入研究患者一般资料、术前实验室检测数据和术后并发症情况,计算控制营养状况(CONUT)评分,统计分析CONUT营养评分在老年胃癌患者接受胃癌D2根治术术后短期并发症的价值。结果 共223例患者纳入研究,CONUT评分的截断值为2.5,肿瘤直径的截断值为2.75 cm。CONUT评分>2.5组的平均年龄高于CONUT评分<2.5组(P=0.005 3),且2组性别构成存在差异,男性患者多于女性(P=0.037 0)。CONUT评分>2.5组患者的肿瘤直径较大(P=0.039 4)。在术后并发症方面,CONUT评分>2.5组的术后并发症多于CONUT评分<2.5组(P=0.008 3)。单因素Logistic回归分析,年龄(OR=1.127;95%CI:1.028~1.236;P=0.011)、CONUT评分(OR=0.339;95%CI:0.151~0.764;P=0.009)是患者发生短期并发症的危险因素。多因素Logistic回归分析显示年龄(OR=1.115;95%CI:1.008~1.233;P=0.035)、CONUT评分(OR=0.414;95%CI:0.175~0.982;P=0.045)是患者发生短期并发症的危险因素。结论 CONUT评分作为老年胃癌患者术前营养评估项目可以有效预测患者术后短期并发症,进而提前进行营养干预,降低术后并发症发生率。
Objective To explore the value of controlling nutritional status score in short-term postoperative complications of elderly patients with gastric cancer.Methods The data of patients who confirmed gastric cancer and treated in the Affiliated Hospital of Jiangsu University from January 2015 to December 2020 were reviewed and analyzed.Patients were selected according to the inclusion criteria and exclusion criteria,the general data,preoperative laboratory test data and postoperative complications of the included patients were collected,and the controlling nutritional status(CONUT)score was calculated.The value of CONUT score in the short-term complications of elderly gastric cancer patients undergoing D2 radical gastrectomy for gastric cancer was evaluated.Results A total of 223 patients were included in this study.The cut-off value of CONUT score was 2.5 and the cut-off value of tumor diameter was 2.75 centimeter.The average age of the group with CONUT score > 2.5 was significantly higher than that of the group with CONUT score < 2.5(P=0.005 3).Moreover,there was significant difference between the sex ratio of the two groups,with male more than female(P=0.037 0).The tumor diameter was significantly larger in the group with CONUT score > 2.5(P=0.039 4).In terms of postoperative complications,there was significantly more postoperative complications in the group with CONUT score > 2.5 than in the group with CONUT score < 2.5(P=0.008 3).Univariate logistic regression analysis showed that age(OR=1.127;95% CI:1.028-1.236;P=0.011)and CONUT score(OR=0.339;95% CI:0.151-0.764;P=0.009)were the risk factors for short-term complications.Multivariate logistic regression analysis showed that age(OR=1.115;95% CI:1.008-1.233;P=0.035)and CONUT score(OR=0.414;95% CI:0.175-0.982;P=0.045)were the risk factors for short-term complications.Conclusions As a preoperative nutritional evaluation item for elderly patients with gastric cancer,CONUT score can effectively predict the short-term postoperative complications of patients,and then carry out nutritional intervention in advance to reduce the incidence of postoperative complications.
1、 SUN H,HUANG X,WANG Z,et al.Triglyceride-to-high density lipoprotein cholesterol ratio predicts clinical outcomes in patients with gastric cancer[J].J Cancer,2019,10(27):6829-6836. SUN H,HUANG X,WANG Z,et al.Triglyceride-to-high density lipoprotein cholesterol ratio predicts clinical outcomes in patients with gastric cancer[J].J Cancer,2019,10(27):6829-6836.
2、 LIANG L,LI J,FU H,et al.Identification of high serum apolipoprotein A1 as a favorable prognostic indicator in patients with multiple myeloma[J].J Cancer,2019,10(20):4852-4859. LIANG L,LI J,FU H,et al.Identification of high serum apolipoprotein A1 as a favorable prognostic indicator in patients with multiple myeloma[J].J Cancer,2019,10(20):4852-4859.
3、 FIORENZA A M,BRANCHI A,SOMMARIVA D.Serum lipoprotein profile in patients with cancer.A comparison with non-cancer subjects[J].Int J Clin Lab Res,2000,30(3):141-145. FIORENZA A M,BRANCHI A,SOMMARIVA D.Serum lipoprotein profile in patients with cancer.A comparison with non-cancer subjects[J].Int J Clin Lab Res,2000,30(3):141-145.
4、 FICHTALI K,BITITI A,ELGHANMI A,et al.Serum lipidomic profiling in breast cancer to identify screening,diagnostic,and prognostic biomarkers[J].Biores Open Access,2020,9(1):1-6. FICHTALI K,BITITI A,ELGHANMI A,et al.Serum lipidomic profiling in breast cancer to identify screening,diagnostic,and prognostic biomarkers[J].Biores Open Access,2020,9(1):1-6.
5、 DAN ZENG C D,TONG Y X,XIAO A T,et al.Peripheral lymphocyte subsets absolute counts as feasible clinical markers for predicting surgical outcome in gastric cancer patients after laparoscopic D2 gastrectomy:A prospective cohort study[J].J Inflamm Res,2021(14):5633-5646. DAN ZENG C D,TONG Y X,XIAO A T,et al.Peripheral lymphocyte subsets absolute counts as feasible clinical markers for predicting surgical outcome in gastric cancer patients after laparoscopic D2 gastrectomy:A prospective cohort study[J].J Inflamm Res,2021(14):5633-5646.
6、 MUNTEANU A,MUNTEANU D,TIGAN S,et al.How do surgical stress and low perioperative serum protein and albumin impact upon short term morbidity and mortality in gastric cancer surgery?[J].Clujul Med,2017,90(1):71-85. MUNTEANU A,MUNTEANU D,TIGAN S,et al.How do surgical stress and low perioperative serum protein and albumin impact upon short term morbidity and mortality in gastric cancer surgery?[J].Clujul Med,2017,90(1):71-85.
7、 KURODA K,TOYOKAWA T,MIKI Y,et al.Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer[J].Sci Rep,2022,12(1):3025. KURODA K,TOYOKAWA T,MIKI Y,et al.Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer[J].Sci Rep,2022,12(1):3025.
8、 CHEN X Y,ZHANG X Z,MA B W,et al.A comparison of four common malnutrition risk screening tools for detecting cachexia in patients with curable gastric cancer[J].Nutrition,2020(70):110498. CHEN X Y,ZHANG X Z,MA B W,et al.A comparison of four common malnutrition risk screening tools for detecting cachexia in patients with curable gastric cancer[J].Nutrition,2020(70):110498.
9、 ARENDS J,BACHMANN P,BARACOS V,et al.ESPEN guidelines on nutrition in cancer patients[J].Clin Nutr,2017,36(1):11-48. ARENDS J,BACHMANN P,BARACOS V,et al.ESPEN guidelines on nutrition in cancer patients[J].Clin Nutr,2017,36(1):11-48.
10、 GIOULBASANIS I,MARTIN L,BARACOS V E,et al.Nutritional assessment in overweight and obese patients with metastatic cancer:does it make sense?[J].Ann Oncol,2015,26(1):217-221. GIOULBASANIS I,MARTIN L,BARACOS V E,et al.Nutritional assessment in overweight and obese patients with metastatic cancer:does it make sense?[J].Ann Oncol,2015,26(1):217-221.
11、 GE X,LIU H,TANG S,et al.Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI:A cohort study[J].Int J Surg,2020(79):294-299. GE X,LIU H,TANG S,et al.Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI:A cohort study[J].Int J Surg,2020(79):294-299.
12、 DINDO D,DEMARTINES N,CLAVIEN P A.Classification of surgical complications:A new proposal with evaluation in a cohort of 6336 patients and results of a survey[J].Ann Surg,2004,240(2):205-213. DINDO D,DEMARTINES N,CLAVIEN P A.Classification of surgical complications:A new proposal with evaluation in a cohort of 6336 patients and results of a survey[J].Ann Surg,2004,240(2):205-213.
13、 朱希山,赵业,马飞艳,等.营养状态评价在胃癌患者全胃切除术预后中的价值[J].2021,101(6):8. 朱希山,赵业,马飞艳,等.营养状态评价在胃癌患者全胃切除术预后中的价值[J].2021,101(6):8.
14、 TOYOKAWA T,KUBO N,TAMURA T,et al.The pretreatment Controlling Nutritional Status(CONUT)score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma:results from a retrospective study[J].BMC cancer,2016,16(1):722. TOYOKAWA T,KUBO N,TAMURA T,et al.The pretreatment Controlling Nutritional Status(CONUT)score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma:results from a retrospective study[J].BMC cancer,2016,16(1):722.
15、 TAKAGI K,YAGI T,UMEDA Y,et al.Preoperative Controlling Nutritional Status(CONUT)score for assessment of prognosis following hepatectomy for hepatocellular carcinoma[J].World J Surg,2017,41(9):2353-2360. TAKAGI K,YAGI T,UMEDA Y,et al.Preoperative Controlling Nutritional Status(CONUT)score for assessment of prognosis following hepatectomy for hepatocellular carcinoma[J].World J Surg,2017,41(9):2353-2360.
16、 HAYAMA T,OZAWA T,OKADA Y,et al.The pretreatment Controlling Nutritional Status(CONUT)score is an independent prognostic factor in patients undergoing resection for colorectal cancer[J].Sci Rep,2020,10(1):13239. HAYAMA T,OZAWA T,OKADA Y,et al.The pretreatment Controlling Nutritional Status(CONUT)score is an independent prognostic factor in patients undergoing resection for colorectal cancer[J].Sci Rep,2020,10(1):13239.
17、 IGNACIO de ULíBARRI J,GONZáLEZ-MADRO?O A,de VILLAR N G,et al.CONUT:a tool for controlling nutritional status.First validation in a hospital population[J].Nutr Hosp,2005,20(1):38-45. IGNACIO de ULíBARRI J,GONZáLEZ-MADRO?O A,de VILLAR N G,et al.CONUT:a tool for controlling nutritional status.First validation in a hospital population[J].Nutr Hosp,2005,20(1):38-45.
18、 SERóN-ARBELOA C,LABARTA-MONZóN L,PUZO-FONCILLAS J,et al.Malnutrition screening and assessment[J].Nutrients,2022,14(12):2392. SERóN-ARBELOA C,LABARTA-MONZóN L,PUZO-FONCILLAS J,et al.Malnutrition screening and assessment[J].Nutrients,2022,14(12):2392.
19、 AHIKO Y,SHIDA D,HORIE T,et al.Controlling nutritional status(CONUT)score as a preoperative risk assessment index for older patients with colorectal cancer[J].BMC cancer,2019,19(1):946. AHIKO Y,SHIDA D,HORIE T,et al.Controlling nutritional status(CONUT)score as a preoperative risk assessment index for older patients with colorectal cancer[J].BMC cancer,2019,19(1):946.
20、 刘兵兵,李增宁.患者主观整体评价法在恶性肿瘤患者营养状况评价中的应用[C]// 中华医学会肠外肠内营养学分会全国肠外肠内营养学术大会. 2014. 刘兵兵,李增宁.患者主观整体评价法在恶性肿瘤患者营养状况评价中的应用[C]// 中华医学会肠外肠内营养学分会全国肠外肠内营养学术大会. 2014.
21、 WEI J M,LI S,CLAYTOR L,et al.Prevalence and predictors of malnutrition in elderly Chinese adults:results from the China Health and Retirement Longitudinal Study[J].Public Health Nutr,2018,21(17):3129-3134. WEI J M,LI S,CLAYTOR L,et al.Prevalence and predictors of malnutrition in elderly Chinese adults:results from the China Health and Retirement Longitudinal Study[J].Public Health Nutr,2018,21(17):3129-3134.
22、 LIU H,JIAO J,ZHU M,et al.Nutritional status according to the Short-Form Mini Nutritional Assessment(MNA-SF)and clinical characteristics as predictors of length of stay,mortality,and readmissions among older inpatients in China:A national study[J].Front Nutr,2022(9):815578. LIU H,JIAO J,ZHU M,et al.Nutritional status according to the Short-Form Mini Nutritional Assessment(MNA-SF)and clinical characteristics as predictors of length of stay,mortality,and readmissions among older inpatients in China:A national study[J].Front Nutr,2022(9):815578.
23、 中华医学会肠外肠内营养学分会老年营养支持学组.老年患者肠外肠内营养支持中国专家共识[J].中华老年医学杂志,2013,32(9):913-929. 中华医学会肠外肠内营养学分会老年营养支持学组.老年患者肠外肠内营养支持中国专家共识[J].中华老年医学杂志,2013,32(9):913-929.
24、 YANG J Y,LEE H J,KIM T H,et al.Short- and long-term outcomes after gastrectomy in elderly gastric cancer patients[J].Ann Surg Oncol,2017,24(2):469-477. YANG J Y,LEE H J,KIM T H,et al.Short- and long-term outcomes after gastrectomy in elderly gastric cancer patients[J].Ann Surg Oncol,2017,24(2):469-477.
25、 CHOI W J,KIM J.Nutritional care of gastric cancer patients with clinical outcomes and complications:A review[J].Clin Nutr Res,2016,5(2):65-78. CHOI W J,KIM J.Nutritional care of gastric cancer patients with clinical outcomes and complications:A review[J].Clin Nutr Res,2016,5(2):65-78.
1、梁亚坤,薛晶,闫帅,等.恶性梗阻性黄疸患者行经皮肝穿刺胆道引流术后出院准备度现状及其影响因素[J].广州医药,2024,55(09):1020-1026. 梁亚坤,薛晶,闫帅,等.恶性梗阻性黄疸患者行经皮肝穿刺胆道引流术后出院准备度现状及其影响因素[J].广州医药,2024,55(09):1020-1026.
2、路威,孙波,魏育涛.控制营养状态评分对COPD食管癌患者行胸腹腔镜McKeown手术预后的影响[J].广东医学,2025,46(11):1741-1746.DOI:10.13820/j.cnki.gdyx.20251322. 路威,孙波,魏育涛.控制营养状态评分对COPD食管癌患者行胸腹腔镜McKeown手术预后的影响[J].广东医学,2025,46(11):1741-1746.DOI:10.13820/j.cnki.gdyx.20251322.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录